Nuvalent, Inc.NUVLNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+68.9%
5Y CAGR+81.9%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+68.9%/yr
Annual compound
5Y CAGR
+81.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
19.9x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$306.97M+41.0%
2024$217.77M+92.3%
2023$113.24M+77.7%
2022$63.73M+79.2%
2021$35.56M+130.9%
2020$15.40M+58.0%
2019$9.75M-